Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies
Jennifer G. Goldman(School of the Art Institute of Chicago), Angela E. Taylor(NIHR Birmingham Biomedical Research Centre), John T. O’Brien(North Tyneside General Hospital), Afina W. Lemstra(Amsterdam Neuroscience), Sonja W. Scholz(Johns Hopkins University), Glenda M. Halliday(The University of Sydney), Dag Aarsland(King's College London), Bradley F. Boeve(Mayo Clinic in Arizona), Manabu Ikeda(The University of Osaka), Douglas Galasko(University of Minnesota), Simon J.G. Lewis(The University of Sydney), Iracema Leroi(Trinity College Dublin), John‐Paul Taylor(School of the Art Institute of Chicago), Helen Bundy Medsger, James E. Galvin(School of the Art Institute of Chicago), Kejal Kantarci(Mayo Clinic), Frederic Blanc(Centre National de la Recherche Scientifique), Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality), James B. Leverenz(VA Puget Sound Health Care System), Irene Litvan(University of California, San Diego)
Cited by 3
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k